The Thrombolysis program is a software module included in the ArMaSoft software.
The Thrombolysis program is designed to quantify the likelihood of acute myocardial ischemia. The term "acute myocardial ischemia" defines such conditions as acute coronary syndrome and acute myocardial infarction.
The objective need for a method of assessing the likelihood of developing these conditions is determined by the fact that approximately 30 percent of patients with developing acute myocardial infarction in the first hours and even days may not have reliable signs of acute myocardial infarction.
The algorithm for determining the likelihood of developing acute myocardial ischemia is based on years of research by Dr. Selker's group. Dr. Selker’s study was performed on 10,000 patients and is rated worldwide as a «Type A» study (top reliability rating). The algorithm is based on a combination with different weights of such signs as gender, age, presence and classification of pain, signs of an electrocardiogram.
With an estimated probability of developing acute myocardial ischemia, 50 percent or more of a patient should be treated as well as with a reliable acute myocardial infarction (in particular, thrombolytic therapy should be used).
Technical and commercial information is indicative, subject to change without notice and is subject to clarification before ordering.
